- Adjusted earnings per share (EPS) surged 24.7% year over year to $0.91 for Q2 2025, topping analyst expectations by $0.13 (non-GAAP). - Despite higher earnings, revenue (GAAP) grew just 2.7% to ...

Mettler-Toledo combines strong margins, efficient growth, and a sticky service model to offset minor tariff risks. See why ...

The Company Delivers Positive Operating Income EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") reported ...

This study proposes a comprehensive strategy to optimize the operation of real-world gas pipeline networks and support decision-making. The goal is to improve environmental sustainability by ...

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) today announced results for the second quarter ended June 29, 2025 and narrowed its full year adjusted diluted ...

Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.